Product: Fusidic acid (sodium salt)
ERGIC2 Overexpression Lysate (Native) Summary
Immunogen |
The lysate was created in HEK293T cells, using plasmid ID RC201479 and based on accession number NM_016570. The protein contains a C-terminal DDK tag.
|
Specificity |
Homo sapiens ERGIC and golgi 2 (ERGIC2), mRNA.
|
Gene |
ERGIC2
|
Applications/Dilutions
Application Notes |
This product is intended for use as a positive control in Western Blot. You will receive the lysate (100ug), and an empty vector negative control (100 ug).
|
Theoretical MW |
42.4 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
Packaging, Storage & Formulations
Storage |
Store at -80C. Avoid freeze-thaw cycles.
|
Buffer |
RIPA buffer
|
Lysate Details for ERGIC2
Type |
Overexpression
|
Protein State |
Native
|
Notes
HEK293T cells in 10-cm dishes were transiently transfected with a non-lipid polymer transfection reagent specially designed and manufactured for large volume DNA transfection. Transfected cells were cultured for 48hrs before collection. The cells were lysed in modified RIPA buffer (25mM Tris-HCl pH7.6, 150mM NaCl, 1% NP-40, 1mM EDTA, 1xProteinase inhibitor cocktail mix, 1mM PMSF and 1mM Na3VO4, and then centrifuged to clarify the lysate. Protein concentration was measured by BCA protein assay kit.This product is manufactured by and sold under license from OriGene Technologies and its use is limited solely for research purposes.
Alternate Names for ERGIC2 Overexpression Lysate (Native)
- cd002
- CD14 protein
- CDA14
- ERGIC and golgi 2
- Erv41
- MGC111152
- PTX1endoplasmic reticulum-Golgi intermediate compartment protein 2
Background
ERGIC2, or PTX1, is a ubiquitously expressed nuclear protein that is downregulated in prostate carcinoma (Kwok et al., 2001 [PubMed 11445006]).[supplied by OMIM].